跳至主要内容
临床试验/CTRI/2019/12/022578
CTRI/2019/12/022578Other2 期

An open label Clinical trial to evaluate the efficacy of Muliv Strong Syrup in the management of Non- Alcoholic Fatty Liver disease (NAFLD).

Multani Pharmaceuticals Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
Other
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients of either sex not taking any medicine will be included in the study.
  • 2. Individuals suffering from NAFLD with or without elevated liver enzymes or hepatomegaly will be included.
  • 3. Patients willing to give informed consent for the study.

排除标准

  • 1. Individuals with chronic hepatitis (more than 3 months), Patients with malignant jaundice, patient with acute hepatitis (Other than infective).
  • 2. Individuals with known hypersensitivity to ingredients of study products; individuals with immediate life threatening diseases such as preexisting cardiovascular, liver, or neoplastic diseases or who received any immunosuppressant, sedative, hypnotic or tranquilizer within 14 days prior to enrollment;
  • 3. Individuals with any psychiatric illness which may impair the ability to provide written ICF.
  • 4. Individuals participating in any other clinical trial.
  • 5. Pregnant or lactating females.
  • 6. Alcohol, smoke, and drug abusers will be excluded from study

研究者

发起方
Multani Pharmaceuticals Ltd

相似试验

Clinical evaluation for the efficacy of Muliv strong... | 临床试验